Tools
ToolsErgin, Busra Donat, Gadsby-Davis, Kieran, Mattishent, Katharina, Dhatariya, Ketan, Garner, Nikki and Hornberger, Michael (2024) Continuous glucose monitoring in comorbid dementia and diabetes – The evidence so far. Journal of Diabetes Science and Technology, 20 (2). pp. 396-402. ISSN 1932-2968
Preview |
PDF (donat-ergin-et-al-2024-continuous-glucose-monitoring-in-comorbid-dementia-and-diabetes-the-evidence-so-far)
- Published Version
Available under License Creative Commons Attribution Non-commercial. Download (315kB) | Preview |
Abstract
Background: Type 2 diabetes mellitus (T2DM) and dementia are two of the leading chronic diseases in aging and are known to influence each other’s disease progression. There is well-established evidence that T2DM increases the risk for cognitive decline and dementia. At the same time, people with cognitive changes or dementia can find it difficult to manage their diabetes, resulting in hyper- or hypoglycemic events which can exacerbate the dementia disease progression further. Monitoring of glucose variability is, therefore, of critical importance during aging and when people with T2DM develop dementia. The advent of continuous glucose monitoring (CGM) has allowed the monitoring of glucose variability in T2DM more closely. The CGM seems to be highly feasible and acceptable to use in older people with T2DM and has been shown to significantly reduce their hypoglycemic events, often resulting in falls. Less is known as to whether CGM can have a similar beneficial effect on people with T2DM who have cognitive impairment or dementia in community or hospital settings. Aims: The current perspective will explore how CGM has made an impact on T2DM management in older people and those with comorbid cognitive impairment or dementia. We will further explore opportunities and challenges of using CGM in comorbid T2DM and dementia in community and hospital settings.
| Item Type: | Article |
|---|---|
| Additional Information: | Publisher Copyright: © 2024 Diabetes Technology Society. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| Uncontrolled Keywords: | alzheimer’s diseases,cgm device,continuous glucose monitoring,dementia,type 2 diabetes mellitus,bioengineering,internal medicine,biomedical engineering,endocrinology, diabetes and metabolism,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/1500/1502 |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School Faculty of Medicine and Health Sciences > School of Health Sciences |
| UEA Research Groups: | Faculty of Science > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Health Promotion Faculty of Medicine and Health Sciences > Research Groups > Nutrition and Preventive Medicine Faculty of Medicine and Health Sciences > Research Centres > Mental Health and Social Care (fka Lifespan Health) Faculty of Medicine and Health Sciences > Research Centres > Norwich Institute for Healthy Aging Faculty of Medicine and Health Sciences > Research Groups > Mental Health Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health Faculty of Medicine and Health Sciences > Research Centres > Public Health |
| Related URLs: | |
| Depositing User: | LivePure Connector |
| Date Deposited: | 27 Nov 2024 10:47 |
| Last Modified: | 05 Mar 2026 08:30 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/97785 |
| DOI: | 10.1177/19322968241301058 |
Downloads
Downloads per month over past year
Actions (login required)
 |
View Item |